Aroa Biosurgery Ltd · ASX:ARX
Aroa Biosurgery — Bell Potter Healthcare Conference November 2023
14 slides from Aroa Biosurgery's conference presentation, Nov 14, 2023
Slide 1: Aroa Biosurgery (ARX) Bell Potter Healthcare Conference November 2023
For personal use only AROA BIOSURGERY (ARX) BELL POTTER HEALTHCARE CONFERENCE NOVEMBER 2023 Unlocking regenerative healing for everybody
Slide 2: Important Notice and Disclaimer
|2 Important Notice and Disclaimer This presentation (Presentation) is dated 14th November 2023 and has been prepared by Aroa Biosurgery Ltd, New Zealand company number 1980577, ARBN 638 867 473 (AROA or the Company). Information in this Presentation The information in this Presentation is of a gene
Slide 3: AROA at a Glance
|3 AROA at a Glance Well established high-growth soft tissue regeneration company For personal use only Four product AROA ECM™ platform families for new products, line >US$3b1 TAM predominantly sold to US extensions & enables AROA’s hospitals for existing products tissue apposition platform US Direc
Slide 4: AROA ECM – Structure & Biology for Regenerative Healing
|4 AROA ECM – Structure & Biology for Regenerative Healing Unique Extracellular Matrix (ECM) derived from ovine forestomach with proven tissue regeneration properties across multiple products1-6 For personal use only 1. Irvine, S. M., et al. (2011). "Quantification of in vitro and in vivo angiogenes
Slide 5: Clinical Evidence
|5 For personal use only Clinical Evidence Barnaby May, PhD Chief Scientific Officer, Aroa Biosurgery Limited
Slide 6: Clinical Research
|6 Clinical Research Projects Initiatives FY2024 FY2025 FY2026 For personal use only • Prospective observation registry Registry • N=300 complex soft tissue reconstructions (225 recruited) • N=10 US sites (9 sites operational) Pivotal • Prospective intervention Myriad/NPWT study in acute Study recon
Slide 7: AROA ECM - restores functional tissue
|7 AROA ECM - restores functional tissue For personal use only 96 PRESENTATIONS/ 46 PRESENTATIONS/ 37 PRESENTATIONS/ PUBLICATIONS PUBLICATIONS PUBLICATIONS Volumetric fill- Rapid Tolerated and No negative formation of well contaminated field inflammatory vascularized and resistant to infection3,5 re
Slide 8: Myriad - complex surgical reconstruction
|8 Myriad™ - complex surgical reconstruction For personal use only •Inpatient complex reconstruction of Day 0 Myriad™ application Day 8 Day 28 volumetric soft tissue defects •Tolerates a contaminated defect[1-3] •Persistent[4-6] •Augments NPWT to potentially reduce duration and complexity of NPWT[4,
Slide 9: Myriad Matrix Clinical Evidence
|9 Myriad Matrix™ Clinical Evidence Reconstruction Sample Contaminated Major Reference Mode Outcomes For personal use only Type Size Fields Complications Chaffin, A. E. and M. C. Buckley Hidradenitis Implant and • No post operative complications or N=8 Yes None (2020) suppurativa dermal recurrence a
Slide 10: OviTex - clinical evidence summary
| 10 OviTex®- clinical evidence summary Goetz et al Sivaraj et al Timmer et Denoto et Sivaraj et al Ankney et Denoto et Parker et al Sawyer Ferzoca 2022 2022 al 2022 al 2022 2022 al 2021 al 2021 2020 2018 2018 For personal use only Participants 28 50 55 19 36 619 76 50 25 31 (n) Ventral, Ventral Her
Slide 11: Endoform - advanced ECM technology available from day 1
| 11 Endoform™ - advanced ECM technology available from day 1 • Outpatient device for the treatment of acute and chronic wounds • Can be used in conjunction with NPWT For personal use only • Reduces time to wound closure by up to 5 weeks, versus standard of care collagen dressing* 2,222 Up to 5.6 we
Slide 12: FY24 Guidance
| 12 FY24 Guidance For personal use only NZ$72-75m 85% NZ$1-2m Product Revenue (YoY CC Product Gross Margin Normalised EBITDA growth 25 – 30%) All guidance is presented on a constant currency ('CC') basis using a NZ$/US$ exchange rate of 0.65, compared to the average exchange rate of 0.62 in FY23. C
Slide 13: Q&A
? For personal use only Q&A Unlocking regenerative healing for everybody
Slide 14: Contact
CONTACT For personal use only James Agnew m +64 21 744 915 investor@aroabio.com Visit our website www.aroa.com and find us on LinkedIn at www.linkedin.com/company/aroa-biosurgery-limited/ 64 Richard Pearse Drive, PO Box 107111, Auckland Airport, Auckland 2150, Auckland 2022, New Zealand New Zealand
Aroa Biosurgery — Bell Potter Healthcare Conference November 2023 on 6ix